Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  1989-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0303-7207(89)90131-7PMID 2521834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A linear analog of atrial natriuretic peptide (ANP) discriminates guanylate cyclase-coupled ANP receptors from non-coupled receptors.

  1988cited by this paper
• The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11.

  1987cited by this paper
• Inactivation of atrial natriuretic factor by the renal brush border.

  1987cited by this paper
• Functional heterogeneity of atrial natriuretic factor receptor in bovine adrenal zona glomerulosa is explained by an amiloride-sensitive high affinity molecular complex.

  1987cited by this paper
• Physiological role of silent receptors of atrial natriuretic factor.

  1987cited by this paper
• Three distinct forms of atrial natriuretic factor receptors: kidney tubular epithelium cells and vascular smooth muscle cells contain different types of receptors.

  1987cited by this paper
• Atrial peptide inactivation by rabbit-kidney brush-border membranes.

  1987cited by this paper
• Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells.

  1986cited by this paper
• Characterization and distribution of receptors for the atrial natriuretic peptides in mammalian brain.

  1986cited by this paper
• Truncated atrial natriuretic peptide analogs. Comparison between receptor binding and stimulation of cyclic GMP accumulation in cultured vascular smooth muscle cells.

  1986cited by this paper
• Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats.

  1986cited by this paper
• Biologically active atrial peptides.

  1985cited by this paper
• Biologically active atrial peptides.

  1985cited by this paper
• Effect of pulmonary and renal circulations on activity of atrial natriuretic factor.

  1985cited by this paper
• New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.

  1985cited by this paper
• An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues.

  1985cited by this paper
• Identification of a receptor for atrial natriuretic factor in rabbit aorta membranes by affinity cross-linking.

  1985cited by this paper
• Specific receptors for atrial natriuretic polypeptide on basolateral membranes isolated from rat renal cortex.

  1985cited by this paper
• Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide.

  1985cited by this paper
• Atriopeptins as cardiac hormones.

  1985cited by this paper
• Specific membrane receptors for atrial natriuretic factor in renal and vascular tissues.

  1984cited by this paper
• Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa.

  1984cited by this paper
• Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitors.

  1984cited by this paper
• Depressor and natriuretic activities of several atrial peptides.

  1984cited by this paper
• Atrial natriuretic factor and urinary kallikrein in the rat: antagonistic factors?

  1984cited by this paper
• Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.

  1984cited by this paper
• Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography.

  1983cited by this paper
• Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides.

  1983cited by this paper
• Endopeptidase-24.11 purified from pig intestine is differently glycosylated from that in kidney.

  1983cited by this paper
• New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.

  1983cited by this paper
• Purification and specificity of a membrane-bound metalloendopeptidase from bovine pituitaries.

  1981cited by this paper
• Rational design of enkephalinase inhibitors: substrate specificity of enkephalinase studied from inhibitory potency of various dipeptides.

  1980cited by this paper
• The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice

  1980cited by this paper
• The purification and specificity of a neutral endopeptidase from rabbit kidney brush border.

  1974cited by this paper

• Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma

  2020cites this paper
• Investigation of the vasoprotective role of C-type natriuretic peptide

  2010cites this paper
• Recent Advances in the Cytobiology of Leukemias* CD10 IN ACUTE LEUKEMIAS

  2005cites this paper
• EFFECTS OF A NEUTRAL ENDOPROTEASE ENZYME INHIBITOR, THIORPHAN, ON HEMODYNAMICS AND RENAL EXCRETORY FUNCTION IN FOUR MODELS OF EXPERIMENTAL HYPERTENSION

  2000cites this paper
• CGS 30440 : A Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral Endopeptidase 24

  1999cites this paper
• Metabolism of bradykinin by the rat coronary vascular bed.

  1998cites this paper
• Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.

  1998cites this paper
• Detection of neutral endopeptidase 24.11 (neprilysin) in human hepatocellular carcinomas by immunocytochemistry.

  1997cites this paper
• CD10 IN ACUTE LEUKEMIAS

  1997cites this paper
• CD10 in acute leukemias. GEIL (Groupe d'Etude Immunologique des Leucémies).

  1997cites this paper
• Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea‐pig lung parenchyma

  1996cites this paper
• Pharmacokinetics and renal metabolism of atrial natriuretic factor during rat pregnancy.

  1996cites this paper
• Neutral endopeptidase inhibitors and the pulmonary circulation.

  1996cites this paper
• Pharmacology of S21402 (RB105): A Dual Inhibitor of Neutral Endopeptidase and Angiotensin Converting Enzyme

  1996cites this paper
• Cardiorenal consequences of dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibition in transgenic rats with an extra renin gene.

  1996cites this paper
• Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.

  1996cites this paper
• A rapid indirect method to determine the plasma concentrations of neutral endopeptidase inhibitors.

  1995cites this paper
• Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.

  1995cites this paper
• Effect of endopeptidase‐24.11 inhibitors and C‐ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide

  1995cites this paper
• Intracellular production of beta A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein.

  1995cites this paper
• Endothelin as a Regulator of Vascular Tone in Man: Studies in Upper Limb Resistance and Capacitance Vessels

  1995cites this paper
• Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase

  1995cites this paper
• Contribution of endogenous generation of endothelin-1 to basal vascular tone.

  1994cites this paper
• CGS 24128: A Long-Acting Inhibitor of Neutral Endopeptidase 3.4.24.11

  1994cites this paper
• Role of atrial natriuretic peptide in the control of sodium balance in chronic renal failure.

  1994cites this paper
• Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.

  1994cites this paper
• Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.

  1994cites this paper
• Effects of the neutral endopeptidase inhibitor, SCH 42495, on the cardiovascular remodelling secondary to chronic hypoxia in rats.

  1994cites this paper
• Acute renal effects of neutral endopeptidase inhibition in humans.

  1994cites this paper
• Phosphoramidon-sensitive conversion of big endothelin-1 and degradation of endothelin-1 in rat kidney.

  1994cites this paper
• Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.

  1994cites this paper
• Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.

  1994cites this paper
• Effect of pregnancy on the vasodepressor response to atrial natriuretic factor.

  1993cites this paper
• Characterization of the thermolysin-like cleavage of biologically active peptides by Xenopus laevis peptide hormone inactivating enzyme.

  1993cites this paper
• Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.

  1993cites this paper
• Nonlinear mixed effect modeling of the pharmacodynamics of natriuretic peptides in rats

  1993cites this paper
• Transforming growth factor-beta 1 inhibits enkephalinase (EC 3.4.24.11) gene expression in human endometrial stromal cells and sex skin fibroblasts in culture.

  1993cites this paper
• Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.

  1993cites this paper
• Cellular localization of membrane metalloendopeptidase (enkephalinase) in human endometrium during the ovarian cycle.

  1993cites this paper
• Neutral endopeptidase 24.11: a modulator of natriuretic peptides.

  1993cites this paper
• Effects of neutral endopeptidase inhibition on the clearance of exogenously administered endothelin in Sprague-Dawley rats.

  1993cites this paper
• Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.

  1993cites this paper
• Effect of endopeptidase‐24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat

  1993cites this paper
• Role of neutral endopeptidase in the metabolism of endothelin.

  1992cites this paper
• Receptors of atrial natriuretic factor.

  1992cites this paper
• Localization of components of the kallikrein-kinin system in the kidney: relation to renal function. State of the art lecture.

  1992cites this paper
• Atrial natriuretic peptide: synthesis, release, and metabolism.

  1992cites this paper
• Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C‐ANP receptor ligand in the rat

  1992cites this paper
• Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor.

  1992cites this paper
• A membrane-bound metallo-endopeptidase from rat kidney. Characteristics of its hydrolysis of peptide hormones and neuropeptides.

  1992cites this paper
• A peptide-hormone-inactivating endopeptidase in Xenopus laevis skin secretion.

  1992cites this paper
• Binding of [125I]atrial natriuretic factor to mouse lung membranes in vivo: characterization and effects of peptidase inhibitors.

  1992cites this paper
• Degradation and inactivation of rat atrial natriuretic peptide 1-28 by neutral endopeptidase-24.11 in rat pulmonary membranes.

  1992cites this paper
• Endothelin 1 hydrolysis by rat kidney membranes

  1992cites this paper
• Characterization of a simian virus 40‐transformed human podocyte cell line producing type IV collagen and exhibiting polarized response to atrial natriuretic peptide

  1992cites this paper
• Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.

  1992cites this paper
• A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.

  1992cites this paper
• Natriuretic peptides A family of hormones.

  1992cites this paper
• Therapeutic use of atrial natriuretic factor.

  1992cites this paper
• Effects of the Selective Neutral Endopeptidase Inhibitor, Retrothiorphan, on Renal Function and Blood Pressure in Conscious Normotensive Wistar and Hypertensive DOCA-Salt Rats

  1992cites this paper
• Atrial Natriuretic Factor

  1991cites this paper
• Assays for Enzymes That Metabolize Atrial Natriuretic Peptide

  1991cites this paper
• Antihypertensive Activity During Inhibition of Neutral Endopeptidase and Angiotensin Converting Enzyme

  1991cites this paper
• SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator.

  1991cites this paper
• [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].

  1991cites this paper
• Neutral Endopeptidase Inhibitors and Atrial Natriuretic Peptide

  1991cites this paper
• The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats.

  1991cites this paper
• Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats.

  1991cites this paper
• Hydrolysis of intact and Cys-Phe-cleaved human atrial natriuretic peptide in vitro by human tissue kallikrein.

  1991cites this paper
• Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.

  1991cites this paper
• Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.

  1991cites this paper
• Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs.

  1991cites this paper
• Antihypertensive and Renal Activity of SQ 28,603, an Inhibitor of Neutral Endopeptidase

  1991cites this paper
• Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.

  1991cites this paper
• Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.

  1991cites this paper
• Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins.

  1991cites this paper
• Progesterone-regulated cyclic modulation of membrane metalloendopeptidase (enkephalinase) in human endometrium.

  1991cites this paper
• Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats.

  1991cites this paper
• Endothelin receptors cloned, endothelin converting enzyme characterized and pathophysiological roles for endothelin proposed.

  1991cites this paper
• Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

  1991cites this paper
• Hemodynamic and Hormonal Effects of Neutral Endopeptidase Inhibitor SCH 39370 in Sheep

  1991cites this paper
• Design and Therapeutic Potential of Peptides

  1991cites this paper
• Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.

  1991cites this paper
• Impaired natriuretic response to atrial natriuretic peptide in the isolated kidney of rats with experimental cirrhosis.

  1990cites this paper
• Chronic Atriopeptin Regulation of Arterial Pressure in Conscious Hypertensive Rats

  1990cites this paper
• Drugs Inhibiting the Metabolism and Inactivation of Atrial Natriuretic Factor: Pharmacological Actions and Therapeutic Implications

  1990cites this paper
• Kinetics of 125I-atrial natriuretic factor after endopeptidase 24.11 inhibition by thiorphan in conscious rabbits

  1990cites this paper
• Characterization of atrial natriuretic factor receptors in human glomerular epithelial and mesangial cells.

  1990cites this paper
• Atrial Natriuretic Factor Plays a Significant Role in Body Fluid Homeostasis

  1990cites this paper
• Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure.

  1990cites this paper
• Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.

  1990cites this paper
• [Atrial natriuretic factor. Current data and future perspectives].

  1990cites this paper
• Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects.

  1990cites this paper
• Angiotensin converting enzyme inhibitor potentiated the vasorelaxant response of atrial natriuretic peptide in toad aortic rings.

  1990cites this paper
• Respective roles ofkallikrein andendopeptidase 24.11 inthe metabolic pathway ofatrial natriuretic peptide intherat

  1990cites this paper
• Effect of endopeptidase 24.11 inhibition in conscious cardiomyopathic hamsters.

  1990cites this paper
• Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.

  1990cites this paper
• Infusion of iso-rANP(1-45) or (17-45) increases plasma immunoreactive ANP and lowers plasma renin activity and aldosterone.

  1990cites this paper
• Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).

  1990cites this paper
• Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation.

  1990cites this paper